Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

WHIRLPOOL CORP /DE/ (WHR)

  • Business News
  • June 12, 2026, 22:20 UTC
  • 7
  • 1 comments

Whirlpool Announces Cash Tender Offer Early Results

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:14 UTC
  • 3
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:13 UTC
  • 4
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:13 UTC
  • 3
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:12 UTC
  • 3
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:11 UTC
  • 4
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:10 UTC
  • 3
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

PHILLIP CAPITAL MANAGEMENT (S) LTD (BYI)

  • Business News
  • June 12, 2026, 22:09 UTC
  • 1
  • 0 comments

General Announcement: Net Tangible Assets (NTA) Per Unit

Market reaction Comment Full text

BANCO SANTANDER S.A. (SAN)

  • Business News
  • June 12, 2026, 22:09 UTC
  • 6
  • 1 comments

Press Release: Sanofi’s Tzield approved in the US as the first disease-modifying therapy for patients recently diagnosed with stage 3 type 1 diabetes

Market reaction Comment Full text

BANCO SANTANDER S.A. (SAN)

  • Business News
  • June 12, 2026, 22:09 UTC
  • 4
  • 1 comments

Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3

Market reaction Comment Full text
  • Previous
  • 2836
  • 2837
  • 2838
  • 2839
  • 2840
  • Next

Search

News categories

  • Technical Exchange News(14168)
  • Event(6229)
  • SEC News(361397)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(222263)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin